• 0 Citations
  • 0 h-Index
20192019
If you made any changes in Pure these will be visible here soon.

Research Output 2019 2019

2019

Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study

Lionetti, R., Piccolo, P., Lenci, I., Siciliano, M., Visco-Comandini, U., De Santis, A., Pompili, M., Milana, M., Taibi, C., Dell'Isola, S., Montalbano, M., Mastroianni, C., Begini, P., Garbuglia, A. R., Angelico, M. & D'Offizi, G., May 1 2019, In : Annals of Hepatology. 18, 3, p. 434-438 5 p.

Research output: Contribution to journalArticle

Open Access
Ribavirin
Hepatitis C
Fibrosis
Genotype
Gastroenterology